http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014080161-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6977a4c74d6288a2d89c7ea18d4447d7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd10498ea531fdab4bbd9d4ff15a4df8 |
| publicationDate | 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014080161-A1 |
| titleOfInvention | Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy |
| abstract | The present invention provides a method of treating a patient suffering from post radical prostatectomy erectile dysfunction (ED RP), in particular iatrogenic reversible erectile dysfunction post radical prostatectomy, comprising the administration of a therapeutically effective amount of a vasoactive intestinal peptide (VDP) and a therapeutically effective amount of an alpha-adrencrgic blocker. Generally the VIP is in the form of a composition having a pH of from around 6 to around 9. |
| priorityDate | 2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.